Skip to main content

Table 7 Drug-likeness properties

From: Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents

Molecule MW No. of H-bond acceptors No. of H-bond donors TPSA WLOGP Lipinski’s RO5 violations
Molecule 4 614.16 7 3 137.17 5.2 1
Molecule 12 662.85 8 3 140.41 4.55 2
Molecule 16 546.42 6 3 94.65 4.76 1
Molecule 27 551.04 6 4 123.75 2.91 1
Molecule 29 579.05 6 4 140.82 2.83 2